Tag Archives: Myriad lawsuit

Australian Patent Office Proposes “Coding Only” Sequence Ban

Coming soon after the High Court’s “Myriad decision” in Australia, the Australian Patent Office has proposed guidelines that would effectively limit the ban on patent-eligibility of DNA sequences to nucleic acids that code for polypeptides. While cDNA is still considered … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , | Leave a comment

Myriad Settles – Questions Remain

Yesterday, Myriad announced it has settled the BRCA assay litigations that had been ongoing—and not going well– with Pathway Genomics, Invitae and Gene by Gene (and I assume….Ambry and Labcorp). Although I was just about at the brink of shouting … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , | Leave a comment

Canadian Hospital To Travel The Long And Winding Road Of “Gene Patenting”

Arguing that human DNA is a natural product, the Children’s Hospital of Eastern Ontario (CHEO) has filed suit in Federal Court to invalidate patents claiming human DNA or diagnostic methods that use it. It has been reported that CHEO was … Continue reading

Posted in Canadian Practice | Tagged , , , , , , , , , , | Leave a comment

Why Myriad Should Drop Its Appeal

In the Kenny Rogers song, “The Gambler,” Rogers sings “You got to know when to hold ‘em, know when to fold ‘em.” There is still time for Myriad to “fold ‘em” and drop its appeal of the district court decision … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | 2 Comments